연구동향 분석
박사

임신중독증 산모의 임신 중기 양수의 cell free RNA 분석을 통한 임신중독증의 병태생리 규명 = Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia

정용욱 2019년

논문상세정보
인용/피인용
' 임신중독증 산모의 임신 중기 양수의 cell free RNA 분석을 통한 임신중독증의 병태생리 규명 = Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Cell free RNA
  • transcriptome
  • 리보솜
  • 생물표지자(biomarker)
  • 양수
  • 임신중독증
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
106 0

0.0%

' 임신중독증 산모의 임신 중기 양수의 cell free RNA 분석을 통한 임신중독증의 병태생리 규명 = Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia' 의 참고문헌

  • Zhong XY, Holzgreve W, Tercanli S, Wenzel F, Hahn S. Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid. Arch Gynecol Obstet. 2006;273(4):221-6.
  • Warner JR, McIntosh KB. How common are extraribosomal functions of ribosomal proteins? Mol Cell. 2009;34(1): 3-11.
  • Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005;25(5):341-8.
  • Tsumita T, Iwanaga M. Fate of injected deoxyribonucleic acid in mice. Nature. 1963;198(15):1088-9.
  • Textoris J, Ivorra D, Ben Amara A, Sabatier F, M nard JP, Heckenroth H, Bretelle F, Mege JL. Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker. PLoS One. 2013;8(12):e82638.
  • Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P. The origin and mechanism of circulating DNA. Ann N Y Acad Sci. 2000;906:161-8.
  • Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Biahcni DW. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A 2009;106(23):9425-9.
  • Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010 Jun;63(6):534-43.
  • Porreco RP, Garite TJ, Maurel K, Marusiak B; Obstetrix Collaborative Research Network, Ehrich M, van den Boom D, Deciu C, Bombard A.Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.Am J Obstet Gynecol. 2014;211(4): 365.e1-12.
  • Phillips JK, Bernstein IM, Mongeon JA, Badger GJ. Seasonal variation in preeclampsia based on timing of conception. Obstet Gynecol. 2004;104(5 Pt 1):1015-20.
  • Peter I, Tighiouart H, Lapaire O, Johnson KL, Bianchi DW, Terrin N. Cell-free DNA fragmentation patterns in amniotic fluid identify genetic abnormalities and changes due to storage. Diagn Mol Pathol. 2008;17(3):185-90.
  • Masuzaki H, Miura K, Yoshiura KI, Yoshimura S, Niikawa N, Ishimaru T. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet. 2004;41(4):289-92.
  • Massingham LJ, Johnson KL, Scholl TM, Slonim DK, Wick HC, Bianchi DW. Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome. Hum Genet 2014;133(9):1075-82.
  • Magnus P, Eskild A. Seasonal variation in the occurrence of pre-eclampsia. BJOG. 2001 Nov;108(11):1116-9.
  • Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64(1):218-24.
  • Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62(4):768-75
  • Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485-7.
  • Les acides nucleiques 여 plasma sanguin chez l'homme
    Mandel P. Metais P. C R Seances Soc Biol Fil. ;142(3-4): 241-243 [1948]
  • Larrabee PB, Johnson KL, Peter I, Bianchi DW. Presence of filterable and nonfilterable cell-free mRNA in amniotic fluid. Clin Chem. 2005a;51(6):1024-6.
  • Larrabee PB, Johnson KL, Pestova E, Lucas M, Wilber K, LeShane ES, Tantravahi U, Cowan JM, Bianchi DW. Microarray analysis of cell-free fetal DNA in amniotic fluid: a prenatal molecular karyotype. Am J Hum Genet. 2004;75(3):485-91.
  • Larrabee PB, Johnson KL, Lai C, Ordovas J, Cowan JM, Tantravahi U, Bianchi DW. Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA 2005b;293(7):836-42.
  • Lapaire O, Bianchi DW, Peter I, O'Brien B, Stroh H, Cowan JM, Tantravahi U, Johnson KL. Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses. Clin Chem. 2007;53(3):405-11.
  • Kuppermann M, Pena S, Bishop JT, Nakagawa S, Gregorich SE, Sit A, Vargas J, Caughey AB, Sykes S, Pierce L, Norton ME. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA. 2014;312(12):1210-7
  • Koide K, Slonim DK, Johnson KL, Tantravahi U, Cowan JM, Bianchi DW. Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet 2011;129(3):295-305.
  • Kang JH, Song H, Yoon JA, Park DY, Kim SH, Lee KJ, Farina A, Cho YK, Kim YN, Park SW, Kim GJ, Shim SH, Cha DH. Preeclampsia leads to dysregulation of various signaling pathways in placenta. J Hypertens. 2011;29(5):928-36.
  • Kang JH, Park HJ, Jung YW, Shim SH, Sung SR, Park JE, Cha DH, Ahn EH. Comparative Transcriptome Analysis of Cell-Free Fetal RNA from Amniotic Fluid and RNA from Amniocytes in Uncomplicated Pregnancies. PLoS One. 2015;10(7):e0132955
  • Kamath-Rayne BD, Du Y, Hughes M, Wagner EA, Muglia LJ, DeFranco EA, Whitsett JA, Salomonis N, Xu Y. Systems biology evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity. BMC Med Genomics 2015;8:67.
  • Jung YW, Shim SS, Park JE, Sung SR, Shim SH, Park HR, Cha DH. Analysis of the cell-free amniotic fluid transcriptome expressed during the euploid mid-trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;203:94-8.
  • Jeon YJ, Kim IK, Hong SH, Nan H, Kim HJ, Lee HJ, Masuda ES, Meyuhas O, Oh BH, Jung YK. Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene. 2008;27(31):4344-52.
  • Jang JH, Jung YW, Shim SH, Sin YJ, Lee KJ, Shim SS, Ahn EH, Cha DH. Global gene expression changes of amniotic fluid cell free RNA according to fetal development. Eur J Obstet Gynecol Reprod Biol. 2017;216:104-110.
  • Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4): 1659-1665.
  • Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc. 2009;4(1):44-57.
  • Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta. 2007;1775(1) :181-232.
  • Eun HM. Enzymology primer for recombinant DNA technology. United States: Academic press. 1996. pp1-108.
  • Edlow AG, Vora NL, Hui L, Wick HC, Cowan JM, Bianchi DW. Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study. PLoS One. 2014;18(9):e88661.
  • Choi JJ, Reich CF 3rd, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology. 2005;115(1):55-62.
  • Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, To KF, Tong JH, Yuen RK, Shum AS, Chan JK, Chan LY, Yuen JW, Tong YK, Weier JF, Ferlatte C, Leung TN, Lau TK, Lo KW, Lo YM. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol. 2007;170(3):941-50.
  • Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem. 2006;52(12):2211-8.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014 Aug;10(8):466-80.
  • Bianchi DW, LeShane ES, Cowan JM. Large amounts of cell-free fetal DNA are present in amniotic fluid. Clin Chem. 2001;47(10):1867-9.
  • Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.